• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于16S rDNA测序的慢性阻塞性肺疾病急性加重期患者气道微生态分析:中国内蒙古的一项横断面研究

A 16S rDNA sequencing-based analysis of airway microecology in patients with an acute exacerbation of chronic obstructive pulmonary disease: A cross-sectional study in Inner Mongolia, China.

作者信息

Zhu Shu-Fen, Wu Xin-Xin, Guo Yan, Li Peng-Fei, Wang Jing-Ran, Liu Miao, Luo Cheng-Wen, Yuan Xiang-Zhen, Li Shao-Wei

机构信息

Physical Examination Center, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.

Inner Mongolia Medical University, Hohhot, China.

出版信息

Front Med (Lausanne). 2022 Oct 13;9:946238. doi: 10.3389/fmed.2022.946238. eCollection 2022.

DOI:10.3389/fmed.2022.946238
PMID:36314008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9606403/
Abstract

AIM

To study the microecological characteristics of the airway and similarities and differences between healthy people and patients with the acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in Inner Mongolia, and analyze the correlation between the characteristics of the airway microecological structure and clinical indicators of AECOPD patients.

METHODS

Sputum samples from 36 healthy volunteers and 34 patients with AECOPD were detected by 16S rDNA high-throughput sequencing, and the airway microecological characteristics of healthy people and AECOPD patients were revealed by an alpha diversity analysis, beta diversity analysis, and LefSe difference analysis.

RESULTS

There were differences in the airway microecological structure between healthy people and AECOPD patients in Inner Mongolia. The airway microbiota composition of AECOPD patients showed an increase in the abundance of common pathogens and a decrease in the abundance of commensal bacteria, and the airway microbial diversity in AECOPD patients was lower than that in healthy people. Long-term use of inhaled glucocorticoid + long-acting β2 agonist mixture (ICS + LABA), procalcitonin (PCT), blood monocyte count (MONO), hemoglobin (HGB), D-dimer (D-D), and body temperature were negatively correlated with the alpha diversity of the airway micro-ecosystem.

CONCLUSION

The airway microecological composition of the AECOPD population in Inner Mongolia was different from that of the healthy population, and the airway microecological diversity was lower than that of the healthy population. The long-term use of ICS + LABA preparation by patients with AECOPD leads to lower alpha diversity. Alpha diversity was negatively correlated with inflammatory markers (PCT, MONO, D-dimer, body temperature) and HGB in AECOPD patients.

摘要

目的

研究内蒙古地区健康人群与慢性阻塞性肺疾病急性加重期(AECOPD)患者气道的微生态特征及异同,并分析AECOPD患者气道微生态结构特征与临床指标之间的相关性。

方法

采用16S rDNA高通量测序技术检测36例健康志愿者和34例AECOPD患者的痰液样本,通过α多样性分析、β多样性分析和LefSe差异分析揭示健康人群和AECOPD患者的气道微生态特征。

结果

内蒙古地区健康人群与AECOPD患者的气道微生态结构存在差异。AECOPD患者气道微生物群组成显示常见病原体丰度增加,共生菌丰度降低,且AECOPD患者的气道微生物多样性低于健康人群。长期使用吸入性糖皮质激素+长效β2受体激动剂合剂(ICS+LABA)、降钙素原(PCT)、血单核细胞计数(MONO)、血红蛋白(HGB)、D-二聚体(D-D)及体温与气道微生态系统的α多样性呈负相关。

结论

内蒙古地区AECOPD人群的气道微生态组成与健康人群不同,气道微生态多样性低于健康人群。AECOPD患者长期使用ICS+LABA制剂导致α多样性降低。AECOPD患者的α多样性与炎症标志物(PCT、MONO、D-二聚体、体温)及HGB呈负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/2524fdf33f4f/fmed-09-946238-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/71255a2018a6/fmed-09-946238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/6c53e5a848c1/fmed-09-946238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/6c123b2a213f/fmed-09-946238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/f4e9557f91f0/fmed-09-946238-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/6e455c84d068/fmed-09-946238-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/f97338029360/fmed-09-946238-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/2899c6be64cd/fmed-09-946238-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/83a349098079/fmed-09-946238-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/fe3d4217cd3a/fmed-09-946238-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/2524fdf33f4f/fmed-09-946238-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/71255a2018a6/fmed-09-946238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/6c53e5a848c1/fmed-09-946238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/6c123b2a213f/fmed-09-946238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/f4e9557f91f0/fmed-09-946238-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/6e455c84d068/fmed-09-946238-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/f97338029360/fmed-09-946238-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/2899c6be64cd/fmed-09-946238-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/83a349098079/fmed-09-946238-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/fe3d4217cd3a/fmed-09-946238-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647a/9606403/2524fdf33f4f/fmed-09-946238-g010.jpg

相似文献

1
A 16S rDNA sequencing-based analysis of airway microecology in patients with an acute exacerbation of chronic obstructive pulmonary disease: A cross-sectional study in Inner Mongolia, China.基于16S rDNA测序的慢性阻塞性肺疾病急性加重期患者气道微生态分析:中国内蒙古的一项横断面研究
Front Med (Lausanne). 2022 Oct 13;9:946238. doi: 10.3389/fmed.2022.946238. eCollection 2022.
2
Lung Mycobiota α-Diversity Is Linked to Severity in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.肺部真菌群的α多样性与慢性阻塞性肺疾病急性加重期重症患者的病情严重程度相关。
Microbiol Spectr. 2023 Mar 28;11(2):e0506222. doi: 10.1128/spectrum.05062-22.
3
Comprehensive analysis of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity-A prospective, observational study.不同严重程度慢性阻塞性肺疾病患者肠道微生物群的综合分析——一项前瞻性观察性研究
Heliyon. 2024 May 19;10(11):e31512. doi: 10.1016/j.heliyon.2024.e31512. eCollection 2024 Jun 15.
4
The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation.血清降钙素原和高敏C反应蛋白水平在慢性阻塞性肺疾病急性加重期早期诊断中的应用
Exp Ther Med. 2017 Jul;14(1):193-198. doi: 10.3892/etm.2017.4496. Epub 2017 May 23.
5
Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.COPD 加重期痰液微生物组特征及其与临床指标的相关性。
J Transl Med. 2022 Feb 5;20(1):76. doi: 10.1186/s12967-022-03278-x.
6
Association Between Adherence to Maintenance Medication in Patients with COPD and Acute Exacerbation Occurrence and Cost in China: A Retrospective Cohort Database Study.中国 COPD 患者维持药物治疗依从性与急性加重发作及成本的关系:一项回顾性队列数据库研究。
Int J Chron Obstruct Pulmon Dis. 2020 May 4;15:963-971. doi: 10.2147/COPD.S234349. eCollection 2020.
7
Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD.比较吸入性糖皮质激素和全身性糖皮质激素对慢性阻塞性肺疾病急性加重期(AECOPD)患者痰液微生物群的影响。
Front Med (Lausanne). 2021 Feb 26;8:637246. doi: 10.3389/fmed.2021.637246. eCollection 2021.
8
Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.血清降钙素原预测慢性阻塞性肺疾病细菌感染诱发急性加重的最佳截断值:一项前瞻性观察研究。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221108516. doi: 10.1177/14799731221108516.
9
Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.急性加重期和稳定期慢性阻塞性肺疾病粪便微生物特征的变化。
Life Sci. 2021 Jan 15;265:118738. doi: 10.1016/j.lfs.2020.118738. Epub 2020 Nov 10.
10
Association between peripheral blood WBCs C3aR mRNA level and plasma C3a, C3aR, IL-1β concentrations and acute exacerbation of chronic obstructive pulmonary disease.外周血白细胞C3aR mRNA水平与血浆C3a、C3aR、IL-1β浓度及慢性阻塞性肺疾病急性加重之间的关联
Immunobiology. 2022 Jan;227(1):152164. doi: 10.1016/j.imbio.2021.152164. Epub 2021 Dec 9.

引用本文的文献

1
A metagenomic next-generation sequencing (mNGS)-based analysis of bronchoalveolar lavage samples in patients with an acute exacerbation of chronic obstructive pulmonary disease.基于宏基因组下一代测序(mNGS)的慢性阻塞性肺疾病急性加重患者支气管肺泡灌洗液样本分析。
J Mol Histol. 2024 Oct;55(5):709-719. doi: 10.1007/s10735-024-10225-1. Epub 2024 Jul 26.
2
The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.慢性阻塞性肺疾病口腔、气道和肠道微生物群的改变:系统评价和荟萃分析。
Front Immunol. 2024 May 8;15:1407439. doi: 10.3389/fimmu.2024.1407439. eCollection 2024.

本文引用的文献

1
Effects of Inhaled Corticosteroid/Long-Acting β-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial (DISARM).吸入性皮质类固醇/长效β激动剂联合治疗对慢性阻塞性肺疾病患者气道微生物组的影响:一项随机对照临床试验(DISARM)。
Am J Respir Crit Care Med. 2021 Nov 15;204(10):1143-1152. doi: 10.1164/rccm.202102-0289OC.
2
The Role of Respiratory Flora in the Pathogenesis of Chronic Respiratory Diseases.呼吸道菌群在慢性呼吸道疾病发病机制中的作用。
Biomed Res Int. 2021 Aug 14;2021:6431862. doi: 10.1155/2021/6431862. eCollection 2021.
3
Airway microbial communities, smoking and asthma in a general population sample.
大气微生物群落、吸烟与一般人群哮喘。
EBioMedicine. 2021 Sep;71:103538. doi: 10.1016/j.ebiom.2021.103538. Epub 2021 Aug 20.
4
Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors.慢性阻塞性肺疾病中的继发性红细胞增多症:患病率和危险因素。
BMC Pulm Med. 2021 Jul 14;21(1):235. doi: 10.1186/s12890-021-01585-5.
5
The Interactions of Airway Bacterial and Fungal Communities in Clinically Stable Asthma.临床稳定型哮喘患者气道细菌与真菌群落的相互作用
Front Microbiol. 2020 Jul 21;11:1647. doi: 10.3389/fmicb.2020.01647. eCollection 2020.
6
Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations.慢性阻塞性肺疾病加重的定义、病因、发病机制及后果。
Clin Chest Med. 2020 Sep;41(3):421-438. doi: 10.1016/j.ccm.2020.06.007.
7
The sputum microbiome is distinct between COPD and health, independent of smoking history.痰微生物组在 COPD 和健康之间存在差异,与吸烟史无关。
Respir Res. 2020 Jul 14;21(1):183. doi: 10.1186/s12931-020-01448-3.
8
Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease.痰微生物组在嗜酸性慢性阻塞性肺疾病急性加重期的丰富度。
Chin Med J (Engl). 2020 Mar 5;133(5):542-551. doi: 10.1097/CM9.0000000000000677.
9
The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy.肺部微生物组:在维持肺部免疫稳态中的作用及其在癌症发生和治疗中的意义。
Cell Mol Life Sci. 2020 Jul;77(14):2739-2749. doi: 10.1007/s00018-020-03452-8. Epub 2020 Jan 23.
10
-derived flagellin stimulates IL-6 and IL-8 production in human bronchial epithelial cells: A potential mechanism for progression and exacerbation of COPD.源自鞭毛蛋白刺激人支气管上皮细胞中白细胞介素-6和白细胞介素-8的产生:慢性阻塞性肺疾病进展和加重的一种潜在机制。
Exp Lung Res. 2019 Oct;45(8):255-266. doi: 10.1080/01902148.2019.1665147. Epub 2019 Sep 13.